{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:49Z","timestamp":1761864769221,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U20A20363"],"award-info":[{"award-number":["U20A20363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province, China","doi-asserted-by":"crossref","award":["LH2020H039"],"award-info":[{"award-number":["LH2020H039"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04403-2","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:51:20Z","timestamp":1760701880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case report: corneal melting after patch graft in a rheumatoid arthritis patient taking Upadacitinib: paradoxical manifestation or uncontrolled disease activity?"],"prefix":"10.1186","volume":"25","author":[{"given":"Hongling","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"4403_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.1","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018. https:\/\/doi.org\/10.1038\/nrdp.2018.1.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4403_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/ACI.0000000000000844","volume":"22","author":"D Wajnsztajn","year":"2022","unstructured":"Wajnsztajn D, Nche E, Solomon A. Corneal complications of rheumatoid arthritis. Curr Opin Allergy Clin Immunol. 2022;22(5):304\u201313.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"4403_CR3","doi-asserted-by":"crossref","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol. 2002;120(1):15\u20139.","DOI":"10.1001\/archopht.120.1.15"},{"key":"4403_CR4","doi-asserted-by":"crossref","unstructured":"Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33(4):835\u201354, vii.","DOI":"10.1016\/j.rdc.2007.08.002"},{"key":"4403_CR5","doi-asserted-by":"crossref","unstructured":"Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990;9(1):66-73.","DOI":"10.1097\/00003226-199001000-00013"},{"issue":"1","key":"4403_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3\u201315.","journal-title":"Ann Rheum Dis"},{"key":"4403_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112857","author":"AF Radu","year":"2021","unstructured":"Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10112857.","journal-title":"Cells"},{"key":"4403_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biom10071002","author":"J Angelini","year":"2020","unstructured":"Angelini J, Talotta R, Roncato R, Fornasier G, Barbiero G, Dal Cin L, et al. Jak-inhibitors for the treatment of rheumatoid arthritis: a focus on the present and an outlook on the future. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10071002.","journal-title":"Biomolecules"},{"issue":"11","key":"4403_CR9","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1093\/rheumatology\/keaa084","volume":"59","author":"H Kameda","year":"2020","unstructured":"Kameda H, Takeuchi T, Yamaoka K, Oribe M, Kawano M, Zhou Y, et al. Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb\/III study. Rheumatology (Oxford). 2020;59(11):3303\u201313.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"4403_CR10","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/art.39801","volume":"68","author":"JM Kremer","year":"2016","unstructured":"Kremer JM, Emery P, Camp HS, Friedman A, Wang L, Othman AA, et al. A phase IIb study of ABT-494, a selective JAK-1 inhibitor, in patients with rheumatoid arthritis and an inadequate response to anti-tumor necrosis factor therapy. Arthritis Rheumatol. 2016;68(12):2867\u201377.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"4403_CR11","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1136\/bjophthalmol-2017-310671","volume":"102","author":"HM Timlin","year":"2018","unstructured":"Timlin HM, Hall HN, Foot B, Koay P. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit. Br J Ophthalmol. 2018;102(9):1298\u2013302.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4403_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","volume":"10","author":"M Artifoni","year":"2014","unstructured":"Artifoni M, Rothschild PR, Br\u00e9zin A, Guillevin L, Pu\u00e9chal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(2):108\u201316.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4403_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12886-021-02092-1","volume":"21","author":"R Dana","year":"2021","unstructured":"Dana R, Farid M, Gupta PK, Hamrah P, Karpecki P, McCabe CM, et al. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy. BMC Ophthalmol. 2021;21(1):327.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"4403_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.eye.6700616","volume":"17","author":"S Bonini","year":"2003","unstructured":"Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond). 2003;17(8):989\u201395.","journal-title":"Eye (Lond)"},{"issue":"4","key":"4403_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4103\/IJO.IJO_2963_24","volume":"73","author":"CS Font","year":"2025","unstructured":"Font CS, Cortina MS. Neurotrophic keratopathy: update in diagnosis and management. Indian J Ophthalmol. 2025;73(4):483\u201395.","journal-title":"Indian J Ophthalmol"},{"key":"4403_CR16","doi-asserted-by":"publisher","first-page":"7298026","DOI":"10.1155\/2017\/7298026","volume":"2017","author":"Y Cao","year":"2017","unstructured":"Cao Y, Zhang W, Wu J, Zhang H, Zhou H. Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment. J Ophthalmol. 2017;2017:7298026.","journal-title":"J Ophthalmol"},{"key":"4403_CR17","doi-asserted-by":"publisher","first-page":"1048889","DOI":"10.3389\/fimmu.2022.1048889","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang Q, Shi W, Pang Y, Li S. Peripheral ulcerative keratitis, nodular episcleritis, and pulmonary nodules as the initial signs of rheumatic arthritis: a case report. Front Immunol. 2022;13:1048889.","journal-title":"Front Immunol"},{"issue":"6","key":"4403_CR18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1080\/09273948.2022.2037654","volume":"30","author":"K Mehta","year":"2022","unstructured":"Mehta K, Gujjar AP, Babu K. Peripheral ulcerative keratitis in a young lady with systemic lupus erythematosus post Rituximab infusion-a case report. Ocul Immunol Inflamm. 2022;30(6):1312\u20134.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"4403_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/09273948.2022.2091615","volume":"31","author":"A \u00c7akmak","year":"2023","unstructured":"\u00c7akmak A, Akova Y, Y\u0131ld\u0131r\u0131m N. The complete success in refractory Mooren\u2019s ulcer treated with Infliximab. Ocul Immunol Inflamm. 2023;31(4):682\u20138.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"4403_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.clae.2018.11.010","volume":"42","author":"A Mart\u00ednez-Abad","year":"2019","unstructured":"Mart\u00ednez-Abad A, Pi\u00f1ero DP. Pellucid marginal degeneration: detection, discrimination from other corneal ectatic disorders and progression. Contact Lens Anterior Eye. 2019;42(4):341\u20139.","journal-title":"Contact Lens Anterior Eye"},{"issue":"6","key":"4403_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.survophthal.2021.02.013","volume":"66","author":"Y Gupta","year":"2021","unstructured":"Gupta Y, Kishore A, Kumari P, Balakrishnan N, Lomi N, Gupta N, et al. Peripheral ulcerative keratitis. Surv Ophthalmol. 2021;66(6):977\u201398.","journal-title":"Surv Ophthalmol"},{"key":"4403_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001472","author":"I Bonnet","year":"2021","unstructured":"Bonnet I, Rousseau A, Duraffour P, Pouchot J, Nguyen CD, Gabison E, et al. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis. RMD Open. 2021. https:\/\/doi.org\/10.1136\/rmdopen-2020-001472.","journal-title":"RMD Open"},{"key":"4403_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.1439","author":"K Kito","year":"2024","unstructured":"Kito K, Fukuda K, Kishimoto T, Yamashiro K, Yagami A. Treatment of vernal keratoconjunctivitis using Upadacitinib. JAMA Ophthalmol. 2024. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.1439.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"4403_CR24","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1093\/rheumatology\/keab093","volume":"60","author":"F Cohen","year":"2021","unstructured":"Cohen F, Gabison EE, St\u00e9phan S, Belkhir R, Nocturne G, Best AL, et al. Peripheral ulcerative keratitis in rheumatoid arthritis patients taking tocilizumab: paradoxical manifestation or insufficient efficacy? Rheumatology (Oxford). 2021;60(11):5413\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"4403_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, et al. The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol. 2020;80:106210.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"4403_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. Jak-stat signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017;77(5):521\u201346.","journal-title":"Drugs"},{"issue":"Suppl 2","key":"4403_CR27","doi-asserted-by":"publisher","first-page":"ii24","DOI":"10.1093\/rheumatology\/keaa895","volume":"60","author":"B Clarke","year":"2021","unstructured":"Clarke B, Yates M, Adas M, Bechman K, Galloway J. The safety of JAK-1 inhibitors. Rheumatology (Oxford). 2021;60(Suppl 2):ii24\u201330.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4403_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, et al. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med. 2022;386(4):316\u201326.","journal-title":"N Engl J Med"},{"issue":"10290","key":"4403_CR29","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/S0140-6736(21)00589-4","volume":"397","author":"K Reich","year":"2021","unstructured":"Reich K, Teixeira HD, de Bruin-Weller M, Bieber T, Soong W, Kabashima K, et al. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2021;397(10290):2169\u201381.","journal-title":"Lancet"},{"key":"4403_CR30","doi-asserted-by":"publisher","first-page":"1200254","DOI":"10.3389\/fphar.2023.1200254","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Wei M, Zhang J. A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib. Front Pharmacol. 2023;14:1200254.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4403_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/rheumatology\/key339","volume":"58","author":"EH Choy","year":"2019","unstructured":"Choy EH. Clinical significance of Janus kinase inhibitor selectivity. Rheumatology (Oxford). 2019;58(6):953\u201362.","journal-title":"Rheumatology (Oxford)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04403-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04403-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04403-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:51:25Z","timestamp":1760701885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04403-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4403"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04403-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Harbin Medical University. All procedures followed the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and the submission to this journal. Written informed consent was obtained from the patient for publication of this case report and any accompanying images or other personal or clinical details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"580"}}